Log in

The Clorox Stock Forecast, Price & News

-1.25 (-0.62 %)
(As of 12/4/2020 12:00 AM ET)
Today's Range
Now: $199.98
50-Day Range
MA: $207.94
52-Week Range
Now: $199.98
Volume2.07 million shs
Average Volume1.77 million shs
Market Capitalization$25.21 billion
P/E Ratio22.27
Dividend Yield2.21%
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands. It also provides grilling products under the Kingsford and Match Light brands; bags and wraps under the Glad brand; and cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands. In addition, the company offers dressings and sauces primarily under the Hidden Valley brand; water-filtration systems and filters under the Brita brand; and natural personal care products under the Burt's Bees brand. Further, it markets its products under the Ayudin, Clorinda, and Poett brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
The Clorox logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 1.5Dividend Strength: 4.2Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.91 out of 5 stars

Industry, Sector and Symbol

Industry Polishes & sanitation goods
Sub-IndustryHousehold Products



Sales & Book Value

Annual Sales$6.72 billion
Cash Flow$8.74 per share
Book Value$10.40 per share


Net Income$939 million


Market Cap$25.21 billion
Next Earnings Date2/2/2021 (Estimated)
-1.25 (-0.62 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

The Clorox (NYSE:CLX) Frequently Asked Questions

How has The Clorox's stock price been impacted by COVID-19 (Coronavirus)?

The Clorox's stock was trading at $169.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CLX stock has increased by 18.1% and is now trading at $199.98.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of The Clorox?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Clorox in the last year. There are currently 3 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for The Clorox
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than The Clorox?

Wall Street analysts have given The Clorox a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but The Clorox wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is The Clorox's next earnings date?

The Clorox is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for The Clorox

How were The Clorox's earnings last quarter?

The Clorox Company (NYSE:CLX) released its quarterly earnings results on Saturday, November, 7th. The company reported $3.22 earnings per share for the quarter, beating analysts' consensus estimates of $2.32 by $0.90. The firm had revenue of $1.92 billion for the quarter, compared to analysts' expectations of $1.74 billion. The Clorox had a return on equity of 132.72% and a net margin of 16.14%. The company's quarterly revenue was up 27.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.59 EPS.
View The Clorox's earnings history

How often does The Clorox pay dividends? What is the dividend yield for The Clorox?

The Clorox declared a quarterly dividend on Tuesday, November 17th. Shareholders of record on Wednesday, January 27th will be given a dividend of $1.11 per share on Friday, February 12th. This represents a $4.44 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend is Tuesday, January 26th.
View The Clorox's dividend history

What guidance has The Clorox issued on next quarter's earnings?

The Clorox issued an update on its FY 2021 Pre-Market earnings guidance on Monday, November, 2nd. The company provided EPS guidance of 7.70-7.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.69. The company issued revenue guidance of $7.057-7.326 billion, compared to the consensus revenue estimate of $6.93 billion.

What price target have analysts set for CLX?

11 brokers have issued 1 year price objectives for The Clorox's stock. Their forecasts range from $164.00 to $268.00. On average, they anticipate The Clorox's stock price to reach $212.42 in the next twelve months. This suggests a possible upside of 6.2% from the stock's current price.
View analysts' price targets for The Clorox

Who are some of The Clorox's key competitors?

What other stocks do shareholders of The Clorox own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Clorox investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), NVIDIA (NVDA), Verizon Communications (VZ), AT&T (T), The Walt Disney (DIS), The Home Depot (HD), The Procter & Gamble (PG), Intel (INTC) and JPMorgan Chase & Co. (JPM).

Who are The Clorox's key executives?

The Clorox's management team includes the following people:
  • Mr. Benno O. Dorer, Exec. Chairman (Age 56, Pay $5.36M)
  • Ms. Linda Rendle, CEO & Director (Age 42, Pay $2.2M)
  • Mr. Kevin B. Jacobsen, Exec. VP & CFO (Age 54, Pay $1.78M)
  • Mr. Eric H. Reynolds, Exec. VP & COO (Age 50, Pay $1.77M)
  • Ms. Laura Stein, Exec. VP of Corp. Affairs & Gen. Counsel (Age 58, Pay $1.77M)
  • Mr. Jeff R. Baker, VP, Chief Accounting Officer & Corp. Controller (Age 51)
  • Ms. Chau Banks, Sr. VP and Chief Information & Enterprise Analytics Officer (Age 51)
  • Lisah Burhan, VP of Investor Relations
  • Mr. William S. Bailey, Sr. VP of Corp. & Bus. Devel. (Age 54)
  • Ms. Stacey Grier, Sr. VP and Chief Marketing & Strategy Officer (Age 57)

What is The Clorox's stock symbol?

The Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

Who are The Clorox's major shareholders?

The Clorox's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.54%), State Street Corp (5.94%), AQR Capital Management LLC (1.23%), California Public Employees Retirement System (0.83%), Swiss National Bank (0.75%) and Acadian Asset Management LLC (0.72%). Company insiders that own The Clorox stock include A D David Mackay, Andrew J Mowery, Benno O Dorer, Dawn C Willoughby, Denise Garner, Diego J Barral, Eric H Reynolds, Jeff Baker, Kevin B Jacobsen, Laura Stein, Matthew T Laszlo, Michael R Costello and William S Bailey.
View institutional ownership trends for The Clorox

Which major investors are selling The Clorox stock?

CLX stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Donaldson Capital Management LLC, AXA S.A., UBS Asset Management Americas Inc., Morgan Stanley, TD Asset Management Inc., Squarepoint Ops LLC, and New York State Common Retirement Fund. Company insiders that have sold The Clorox company stock in the last year include Andrew J Mowery, Benno O Dorer, Denise Garner, Diego J Barral, Eric H Reynolds, Jeff Baker, Kevin B Jacobsen, Laura Stein, and William S Bailey.
View insider buying and selling activity for The Clorox

Which major investors are buying The Clorox stock?

CLX stock was bought by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, BlackRock Inc., Great West Life Assurance Co. Can, Voloridge Investment Management LLC, Acadian Asset Management LLC, Natixis, Los Angeles Capital Management & Equity Research Inc., and Eudaimonia Partners LLC.
View insider buying and selling activity for The Clorox

How do I buy shares of The Clorox?

Shares of CLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is The Clorox's stock price today?

One share of CLX stock can currently be purchased for approximately $199.98.

How big of a company is The Clorox?

The Clorox has a market capitalization of $25.21 billion and generates $6.72 billion in revenue each year. The company earns $939 million in net income (profit) each year or $7.36 on an earnings per share basis. The Clorox employs 8,800 workers across the globe.

What is The Clorox's official website?

The official website for The Clorox is www.thecloroxcompany.com.

How can I contact The Clorox?

The Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The company can be reached via phone at 510-271-7000 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.